Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 studyEzra E.W. Cohen, Signe Friesland, Denis Soulières et al.|The Lancet|2018Cited by 1.7k
High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivorsLisanne S. Rigter, Monique E. van Leerdam, Manon C.W. Spaander et al.|Cancer|2018Cited by 32
Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study designLisanne S. Rigter, Monique E. van Leerdam, Manon C.W. Spaander et al.|BMC Cancer|2017Cited by 10
Diagnostic Accuracy of Stool Tests for Colorectal Cancer Surveillance in Hodgkin Lymphoma SurvivorsBerbel L.M. Ykema, Monique E. van Leerdam, Lisanne S. Rigter et al.|Journal of Clinical Medicine|2020Cited by 6
Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic RadiotherapyBerbel L.M. Ykema, Iris Lansdorp‐Vogelaar, Andrea Gini et al.|Cancer Epidemiology Biomarkers & Prevention|2022Cited by 4